Skip to main content
Premium Trial:

Request an Annual Quote

Bush Taps MIT s Lander for National Cancer Institute Board

NEW YORK, Jan. 16-President George W. Bush plans to appoint Whitehead Institute/MIT Center for Genome Research director Eric Lander to the National Cancer Advisory Board, the White House said yesterday.


The National Cancer Advisory Board oversees the National Cancer Institute, considering budget, legislative, clinical, scientific, and regulatory issues and providing peer review for NCI grant applications.


Its 18 members are all appointed by the president, and include medical, scientific, administrative, and patient advocate experts. It is currently chaired by University of Wisconsin Comprehensive Cancer Center director John Niederhuber.


Lander, who is also professor of biology at Massachusetts Institute of Technology, will serve on the board until March 2006 and may be re-appointed for a second term.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.